prednisone,cyclophosphamide,rituximab,bendamustine,vincristine,doxorubicin,ibrutinib
janssen,abbvie
['selene', 'lymphoma']
selene aes
largely as expected with some increases in af and bleeding but similar fatal aes in both arms conclusion:
although there is a (small) group of indolent lymphoma patients who benefit from btki, we have failed to find a biomarker to identify this group
#17icml 
haematology registrar | @harvardmed fellow @PORTAL_research | evidence-based medicine & policy | lymphoma | myeloma | Fulbright | writer | SoMe Ed @BrJHaem